Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 781 entries
Sorted by: Best Match Show Resources per page
Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro.

BMC research notes

Said HM, Polat B, Hagemann C, Anacker J, Flentje M, Vordermark D.
PMID: 19144146
BMC Res Notes. 2009 Jan 13;2:8. doi: 10.1186/1756-0500-2-8.

BACKGROUND: Gene expression studies related to cancer diagnosis and treatment are important. In order to conduct such experiment accurately, absolutely reliable housekeeping genes are essential to normalize cancer related gene expression. The most important characteristics of such genes are...

Cite
Said HM, Polat B, Hagemann C, et al. Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro. BMC Res Notes. 2009;2:8doi: 10.1186/1756-0500-2-8.
Said, H. M., Polat, B., Hagemann, C., Anacker, J., Flentje, M., & Vordermark, D. (2009). Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro. BMC research notes, 28. https://doi.org/10.1186/1756-0500-2-8
Said, Harun M, et al. "Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro." BMC research notes vol. 2 (2009): 8. doi: https://doi.org/10.1186/1756-0500-2-8
Said HM, Polat B, Hagemann C, Anacker J, Flentje M, Vordermark D. Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro. BMC Res Notes. 2009 Jan 13;2:8. doi: 10.1186/1756-0500-2-8. PMID: 19144146; PMCID: PMC2646737.
Copy Download .nbib Format: NLM
The effect of liposome treatment on the quality of hypothermically stored red blood cells.

Biopreservation and biobanking

Stadnick H, Stoll C, Wolkers WF, Acker JP, Holovati JL.
PMID: 24836629
Biopreserv Biobank. 2011 Dec;9(4):335-42. doi: 10.1089/bio.2011.0023. Epub 2011 Nov 10.

Recent studies have demonstrated that liposome treatment of red blood cells (RBCs) leads to improved recovery and membrane integrity following cryopreservation protocols. However, the effect of liposome treatment on hypothermically stored RBCs has not been previously investigated. The current...

Cite
Stadnick H, Stoll C, Wolkers WF, et al. The effect of liposome treatment on the quality of hypothermically stored red blood cells. Biopreserv Biobank. 2011;9(4):335-42doi: 10.1089/bio.2011.0023.
Stadnick, H., Stoll, C., Wolkers, W. F., Acker, J. P., & Holovati, J. L. (2011). The effect of liposome treatment on the quality of hypothermically stored red blood cells. Biopreservation and biobanking, 9(4), 335-42. https://doi.org/10.1089/bio.2011.0023
Stadnick, Hart, et al. "The effect of liposome treatment on the quality of hypothermically stored red blood cells." Biopreservation and biobanking vol. 9,4 (2011): 335-42. doi: https://doi.org/10.1089/bio.2011.0023
Stadnick H, Stoll C, Wolkers WF, Acker JP, Holovati JL. The effect of liposome treatment on the quality of hypothermically stored red blood cells. Biopreserv Biobank. 2011 Dec;9(4):335-42. doi: 10.1089/bio.2011.0023. Epub 2011 Nov 10. PMID: 24836629.
Copy Download .nbib Format: NLM
Impact of ultrasound contrast agent on the detection of thrombi during transoesophageal echocardiography.

Open heart

Ebelt H, Offhaus A, Wiora M, Roehl P, Schwenzky A, Weida A, Hoyme M, Bindemann-Koecher J, Anacker J.
PMID: 31673382
Open Heart. 2019 Sep 26;6(2):e001024. doi: 10.1136/openhrt-2019-001024. eCollection 2019.

BACKGROUND: Atrial fibrillation (AF) carries the risk of thrombus formation in the left atrium and especially in the left atrial appendage (LAA). A transoesophageal echocardiography (TOE) is routinely performed in these patients to rule out thrombi before cardioversion or...

Cite
Ebelt H, Offhaus A, Wiora M, et al. Impact of ultrasound contrast agent on the detection of thrombi during transoesophageal echocardiography. Open Heart. 2019;6(2):e001024doi: 10.1136/openhrt-2019-001024.
Ebelt, H., Offhaus, A., Wiora, M., Roehl, P., Schwenzky, A., Weida, A., Hoyme, M., Bindemann-Koecher, J., & Anacker, J. (2019). Impact of ultrasound contrast agent on the detection of thrombi during transoesophageal echocardiography. Open heart, 6(2), e001024. https://doi.org/10.1136/openhrt-2019-001024
Ebelt, Henning, et al. "Impact of ultrasound contrast agent on the detection of thrombi during transoesophageal echocardiography." Open heart vol. 6,2 (2019): e001024. doi: https://doi.org/10.1136/openhrt-2019-001024
Ebelt H, Offhaus A, Wiora M, Roehl P, Schwenzky A, Weida A, Hoyme M, Bindemann-Koecher J, Anacker J. Impact of ultrasound contrast agent on the detection of thrombi during transoesophageal echocardiography. Open Heart. 2019 Sep 26;6(2):e001024. doi: 10.1136/openhrt-2019-001024. eCollection 2019. PMID: 31673382; PMCID: PMC6803001.
Copy Download .nbib Format: NLM
Quality Assessment of Established and Emerging Blood Components for Transfusion.

Journal of blood transfusion

Acker JP, Marks DC, Sheffield WP.
PMID: 28070448
J Blood Transfus. 2016;2016:4860284. doi: 10.1155/2016/4860284. Epub 2016 Dec 14.

Blood is donated either as whole blood, with subsequent component processing, or through the use of apheresis devices that extract one or more components and return the rest of the donation to the donor. Blood component therapy supplanted whole...

Cite
Acker JP, Marks DC, Sheffield WP. Quality Assessment of Established and Emerging Blood Components for Transfusion. J Blood Transfus. 2016;2016:4860284doi: 10.1155/2016/4860284.
Acker, J. P., Marks, D. C., & Sheffield, W. P. (2016). Quality Assessment of Established and Emerging Blood Components for Transfusion. Journal of blood transfusion, 20164860284. https://doi.org/10.1155/2016/4860284
Acker, Jason P, et al. "Quality Assessment of Established and Emerging Blood Components for Transfusion." Journal of blood transfusion vol. 2016 (2016): 4860284. doi: https://doi.org/10.1155/2016/4860284
Acker JP, Marks DC, Sheffield WP. Quality Assessment of Established and Emerging Blood Components for Transfusion. J Blood Transfus. 2016;2016:4860284. doi: 10.1155/2016/4860284. Epub 2016 Dec 14. PMID: 28070448; PMCID: PMC5192317.
Copy Download .nbib Format: NLM
Proliferative and Regenerative Effect of Acetonic Extract of .

World journal of plastic surgery

Rasekh H, Hoseini Farahi M, Mehrabani D, Massoumi SJ, Ramzi M, Acker JP.
PMID: 33330009
World J Plast Surg. 2020 Sep;9(3):313-320. doi: 10.29252/wjps.9.3.313.

BACKGROUND: Feijoa is widely used in medicine due to their anti-inflammatory, antioxidant, antimicrobial and antitumor properties. The current investigation studied the proliferative and regenerative effect of acetonic extract of METHODS: Acetone extract of Feijoa was prepared using percolator and...

Cite
Rasekh H, Hoseini Farahi M, Mehrabani D, et al. Proliferative and Regenerative Effect of Acetonic Extract of . World J Plast Surg. 2020;9(3):313-320doi: 10.29252/wjps.9.3.313.
Rasekh, H., Hoseini Farahi, M., Mehrabani, D., Massoumi, S. J., Ramzi, M., & Acker, J. P. (2020). Proliferative and Regenerative Effect of Acetonic Extract of . World journal of plastic surgery, 9(3), 313-320. https://doi.org/10.29252/wjps.9.3.313
Rasekh, Hosein, et al. "Proliferative and Regenerative Effect of Acetonic Extract of ." World journal of plastic surgery vol. 9,3 (2020): 313-320. doi: https://doi.org/10.29252/wjps.9.3.313
Rasekh H, Hoseini Farahi M, Mehrabani D, Massoumi SJ, Ramzi M, Acker JP. Proliferative and Regenerative Effect of Acetonic Extract of . World J Plast Surg. 2020 Sep;9(3):313-320. doi: 10.29252/wjps.9.3.313. PMID: 33330009; PMCID: PMC7734928.
Copy Download .nbib Format: NLM
Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods.

Journal of blood transfusion

Shih AW, Bhagirath VC, Heddle NM, Acker JP, Liu Y, Eikelboom JW, Liaw PC.
PMID: 27774338
J Blood Transfus. 2016;2016:9316385. doi: 10.1155/2016/9316385. Epub 2016 Sep 27.

No abstract available.

Cite
Shih AW, Bhagirath VC, Heddle NM, et al. Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods. J Blood Transfus. 2016;2016:9316385doi: 10.1155/2016/9316385.
Shih, A. W., Bhagirath, V. C., Heddle, N. M., Acker, J. P., Liu, Y., Eikelboom, J. W., & Liaw, P. C. (2016). Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods. Journal of blood transfusion, 20169316385. https://doi.org/10.1155/2016/9316385
Shih, Andrew W, et al. "Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods." Journal of blood transfusion vol. 2016 (2016): 9316385. doi: https://doi.org/10.1155/2016/9316385
Shih AW, Bhagirath VC, Heddle NM, Acker JP, Liu Y, Eikelboom JW, Liaw PC. Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods. J Blood Transfus. 2016;2016:9316385. doi: 10.1155/2016/9316385. Epub 2016 Sep 27. PMID: 27774338; PMCID: PMC5059535.
Copy Download .nbib Format: NLM
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation.

Cytotherapy

Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP.
PMID: 34688545
Cytotherapy. 2021 Oct 20; doi: 10.1016/j.jcyt.2021.09.006. Epub 2021 Oct 20.

No abstract available.

Cite
Halpenny M, William N, Elmoazzen H, et al. The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy. 2021;doi: 10.1016/j.jcyt.2021.09.006.
Halpenny, M., William, N., Elmoazzen, H., Giulivi, A., Martin, L., Perron, D., Bredeson, C., Hamelin, L., Huebsch, L., Yang, L., Birch, P., & Acker, J. P. (2021). The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy, . https://doi.org/10.1016/j.jcyt.2021.09.006
Halpenny, Michael, et al. "The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation." Cytotherapy vol. (2021). doi: https://doi.org/10.1016/j.jcyt.2021.09.006
Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP. The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy. 2021 Oct 20; doi: 10.1016/j.jcyt.2021.09.006. Epub 2021 Oct 20. PMID: 34688545.
Copy Download .nbib Format: NLM
Emerging Role for Use of Liposomes in the Biopreservation of Red Blood Cells.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Holovati JL, Acker JP.
PMID: 21566711
Transfus Med Hemother. 2011;38(2):99-106. doi: 10.1159/000326841. Epub 2011 Mar 21.

SUMMARY: Biopreservation is the process of maintaining the integrity and functionality of cells held outside the native environment for extended storage times. The development of red blood cell (RBC) biopreservation techniques that maintain in vitro RBC viability and function...

Cite
Holovati JL, Acker JP. Emerging Role for Use of Liposomes in the Biopreservation of Red Blood Cells. Transfus Med Hemother. 2011;38(2):99-106doi: 10.1159/000326841.
Holovati, J. L., & Acker, J. P. (2011). Emerging Role for Use of Liposomes in the Biopreservation of Red Blood Cells. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 38(2), 99-106. https://doi.org/10.1159/000326841
Holovati, Jelena L, and Acker, Jason P. "Emerging Role for Use of Liposomes in the Biopreservation of Red Blood Cells." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 38,2 (2011): 99-106. doi: https://doi.org/10.1159/000326841
Holovati JL, Acker JP. Emerging Role for Use of Liposomes in the Biopreservation of Red Blood Cells. Transfus Med Hemother. 2011;38(2):99-106. doi: 10.1159/000326841. Epub 2011 Mar 21. PMID: 21566711; PMCID: PMC3088733.
Copy Download .nbib Format: NLM
Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

da SilveiraCavalcante L, Acker JP, Holovati JL.
PMID: 26195928
Transfus Med Hemother. 2015 May;42(3):150-7. doi: 10.1159/000371474. Epub 2015 Jan 29.

BACKGROUND: Small animal models have been previously used in transfusion medicine studies to evaluate the safety of blood transfusion products. Although there are multiple studies on the effects of blood banking practices on human red blood cells (RBCs), little...

Cite
da SilveiraCavalcante L, Acker JP, Holovati JL. Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions. Transfus Med Hemother. 2015;42(3):150-7doi: 10.1159/000371474.
da SilveiraCavalcante, L., Acker, J. P., & Holovati, J. L. (2015). Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 42(3), 150-7. https://doi.org/10.1159/000371474
da SilveiraCavalcante, Luciana, et al. "Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 42,3 (2015): 150-7. doi: https://doi.org/10.1159/000371474
da SilveiraCavalcante L, Acker JP, Holovati JL. Differences in Rat and Human Erythrocytes Following Blood Component Manufacturing: The Effect of Additive Solutions. Transfus Med Hemother. 2015 May;42(3):150-7. doi: 10.1159/000371474. Epub 2015 Jan 29. PMID: 26195928; PMCID: PMC4483285.
Copy Download .nbib Format: NLM
Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Jordan A, Acker JP.
PMID: 27330533
Transfus Med Hemother. 2016 Mar;43(2):133-6. doi: 10.1159/000441959. Epub 2015 Nov 05.

BACKGROUND: Residual plasma in transfused red cell concentrates (RCCs) has been associated with adverse transfusion outcomes. Despite this, there is no consensus on the standard procedure for measuring residual plasma volume.METHODS: The volumes of residual plasma and additive solution...

Cite
Jordan A, Acker JP. Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates. Transfus Med Hemother. 2015;43(2):133-6doi: 10.1159/000441959.
Jordan, A., & Acker, J. P. (2016). Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 43(2), 133-6. https://doi.org/10.1159/000441959
Jordan, Andrew, and Acker, Jason P. "Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 43,2 (2016): 133-6. doi: https://doi.org/10.1159/000441959
Jordan A, Acker JP. Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates. Transfus Med Hemother. 2016 Mar;43(2):133-6. doi: 10.1159/000441959. Epub 2015 Nov 05. PMID: 27330533; PMCID: PMC4909359.
Copy Download .nbib Format: NLM
Vox Sanguinis International Forum on platelet cryopreservation.

Vox sanguinis

Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M.
PMID: 28929500
Vox Sang. 2017 Oct;112(7):e69-e85. doi: 10.1111/vox.12532. Epub 2017 Sep 20.

No abstract available.

Cite
Cohn CS, Dumont LJ, Lozano M, et al. Vox Sanguinis International Forum on platelet cryopreservation. Vox Sang. 2017;112(7):e69-e85doi: 10.1111/vox.12532.
Cohn, C. S., Dumont, L. J., Lozano, M., Marks, D. C., Johnson, L., Ismay, S., Bondar, N., T'Sas, F., Yokoyama, A. P. H., Kutner, J. M., Acker, J. P., Bohonek, M., Sailliol, A., Martinaud, C., Pogłód, R., Antoniewicz-Papis, J., Lachert, E., Pun, P. B. L., Lu, J., Cid, J., Guijarro, F., Puig, L., Gerber, B., Alberio, L., Schanz, U., Buser, A., Noorman, F., Zoodsma, M., van der Meer, P. F., de Korte, D., Wagner, S., & O'Neill, M. (2017). Vox Sanguinis International Forum on platelet cryopreservation. Vox sanguinis, 112(7), e69-e85. https://doi.org/10.1111/vox.12532
Cohn, C S, et al. "Vox Sanguinis International Forum on platelet cryopreservation." Vox sanguinis vol. 112,7 (2017): e69-e85. doi: https://doi.org/10.1111/vox.12532
Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M. Vox Sanguinis International Forum on platelet cryopreservation. Vox Sang. 2017 Oct;112(7):e69-e85. doi: 10.1111/vox.12532. Epub 2017 Sep 20. PMID: 28929500.
Copy Download .nbib Format: NLM
Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Almizraq RJ, Holovati JL, Acker JP.
PMID: 29928174
Transfus Med Hemother. 2018 May;45(3):185-193. doi: 10.1159/000486137. Epub 2018 Mar 16.

BACKGROUND: Extracellular vesicles (EVs) in blood products are potential effectors of inflammation and coagulation after transfusion. The aim of this study was to assess the impact of different blood manufacturing methods and duration of hypothermic storage on the EV...

Cite
Almizraq RJ, Holovati JL, Acker JP. Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method. Transfus Med Hemother. 2018;45(3):185-193doi: 10.1159/000486137.
Almizraq, R. J., Holovati, J. L., & Acker, J. P. (2018). Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 45(3), 185-193. https://doi.org/10.1159/000486137
Almizraq, Ruqayyah J, et al. "Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 45,3 (2018): 185-193. doi: https://doi.org/10.1159/000486137
Almizraq RJ, Holovati JL, Acker JP. Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method. Transfus Med Hemother. 2018 May;45(3):185-193. doi: 10.1159/000486137. Epub 2018 Mar 16. PMID: 29928174; PMCID: PMC6006624.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 781 entries